4862.5000 19.00 (0.39%)
NSE Jun 06, 2025 15:31 PM
Volume: 181.8K
 

4862.50
0.39%
Reliance Securities
ff US FDA: Alkem is yet to receive The US FDA clearance for St. Louis facility. However, it has already received EIR for Daman unit (inspected in Mar'18), while the US FDA inspected its Baddi plant between 6-10th Aug-18 with zero observations....
BOB Capital Markets Ltd. released a Sell report for Alkem Laboratories Ltd. with a price target of 4527.0 on 30 May, 2025.
More from Alkem Laboratories Ltd.
Recommended